Prader-Willi综合征中的恶性肿瘤:大型国际队列研究结果与文献回顾
该研究纳入706例Prader-Willi综合征(PWS)患者(160例儿童、546例成人),回顾性收集病历中既往或现存恶性肿瘤、肿瘤类型及危险因素资料,并检索文献分析15q11.2-q13区基因与恶性肿瘤的关系;7例成人确诊恶性肿瘤,均有父源性15q11-13缺失。作者认为PWS患者恶性肿瘤罕见,仅在出现临床相关症状时提示筛查,并鼓励参与国家筛查项目。
要点
- 706例PWS患者中7例成人确诊恶性肿瘤,年龄范围18-55岁,均有父源性15q11-13缺失。
- 文献回顾显示15q11.2-q13区多个基因与恶性肿瘤相关。
- 作者认为PWS患者恶性肿瘤罕见,仅在出现临床相关症状时提示筛查。
核心结论
- 恶性肿瘤在PWS患者中罕见,仅在出现临床相关症状(如不明原因体重下降、食欲减退、提示副肿瘤综合征的症状或定位症状)时提示进行恶性肿瘤筛查。
- 鉴于肥胖相关癌症风险增加,而肥胖在PWS中常见,应鼓励患者参与国家筛查项目。
研究设计与样本
- 研究纳入706例PWS患者(160例儿童、546例成人),回顾性收集病历中既往或现存恶性肿瘤、恶性肿瘤类型及恶性肿瘤危险因素的数据。
- 同时检索文献,获取15q11.2-q13区基因与恶性肿瘤关系的信息。
主要发现
- 7例成人(年龄范围18-55岁)被诊断为恶性肿瘤,包括急性淋巴细胞白血病、颅内血管外皮细胞瘤、黑色素瘤、胃腺癌、胆道癌、腮腺腺癌和结肠癌。
- 所有恶性肿瘤患者均有父源性15q11-13缺失。
- 文献回顾显示15q11.2-q13区多个基因与恶性肿瘤相关。
临床怎么用
- 作者认为,PWS患者仅在出现临床相关症状时才提示进行恶性肿瘤筛查,症状包括不明原因体重下降、食欲减退、提示副肿瘤综合征的症状或定位症状。
- 作者建议,鉴于肥胖相关癌症风险增加且肥胖在PWS中常见,应鼓励PWS患者参与国家筛查项目。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Prader-Willi syndrome (PWS) is a complex disorder combining hypothalamic dysfunction, neurodevelopmental delay, hypotonia, and hyperphagia with risk of obesity and its complications. PWS is caused by the loss of expression of the PWS critical region, a cluster of paternally expressed genes on chromosome 15q11.2-q13. As life expectancy of patients with PWS increases, age-related diseases like malignancies might pose a new threat to health. OBJECTIVE: To investigate the prevalence and risk factors of malignancies in patients with PWS and to provide clinical recommendations for cancer screening. METHODS: We included 706 patients with PWS (160 children, 546 adults). We retrospectively collected data from medical records on past or current malignancies, the type of malignancy, and risk factors for malignancy. Additionally, we searched the literature for information about the relationship between genes on chromosome 15q11.2-q13 and malignancies. RESULTS: Seven adults (age range, 18-55 years) had been diagnosed with a malignancy (acute lymphoblastic leukemia, intracranial hemangiopericytoma, melanoma, stomach adenocarcinoma, biliary cancer, parotid adenocarcinoma, and colon cancer). All patients with a malignancy had a paternal 15q11-13 deletion. The literature review showed that several genes on chromosome 15q11.2-q13 are related to malignancies. CONCLUSION: Malignancies are rare in patients with PWS. Therefore, screening for malignancies is only indicated when clinically relevant symptoms are present, such as unexplained weight loss, loss of appetite, symptoms suggestive of paraneoplastic syndrome, or localizing symptoms. Given the increased cancer risk associated with obesity, which is common in PWS, participation in national screening programs should be encouraged.
引用
- Pellikaan K, Nguyen NQC, Rosenberg AGW, et al. Malignancies in Prader-Willi Syndrome: Results From a Large International Cohort and Literature Review. J Clin Endocrinol Metab. 2023. PMID: 37267430. doi:10.1210/clinem/dgad312
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。